EKJCX
Price
$3.22
Change
-$0.08 (-2.42%)
Updated
Nov 13 closing price
Net Assets
1.48B
GFACX
Price
$74.18
Change
-$1.66 (-2.19%)
Updated
Nov 13 closing price
Net Assets
340.4B
Interact to see
Advertisement

EKJCX vs GFACX

Header iconEKJCX vs GFACX Comparison
Open Charts EKJCX vs GFACXBanner chart's image
Allspring Premier Large Co Gr C
Price$3.22
Change-$0.08 (-2.42%)
VolumeN/A
Net Assets1.48B
American Funds Growth Fund of Amer C
Price$74.18
Change-$1.66 (-2.19%)
VolumeN/A
Net Assets340.4B
EKJCX vs GFACX Comparison Chart in %
View a ticker or compare two or three
VS
EKJCX vs. GFACX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EKJCX is a Buy and GFACX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 340B vs. EKJCX (1.48B). EKJCX (0.00) and GFACX (0.00) have matching dividends . EKJCX was incepted earlier than GFACX: EKJCX (28 years) vs GFACX (25 years). EKJCX (1.90) is less costly to investors than GFACX (1.36). EKJCX is a more actively managed with annual turnover of: 63.00 vs. GFACX (25.00). GFACX has a lower initial minimum investment than EKJCX: GFACX (250) vs EKJCX (1000). GFACX annual gain was more profitable for investors over the last year : 4.61 vs. EKJCX (-35.73). GFACX return over 5 years is better than : 27.87 vs. EKJCX (-74.20).
EKJCXGFACXEKJCX / GFACX
Total Expense Ratio1.851.36136%
Annual Report Gross Expense Ratio1.901.36140%
Fund Existence28 years25 years-
Gain YTD15.00016.34392%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.48B340B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year-35.734.61-775%
Returns for 3 years-45.4256.17-81%
Returns for 5 years-74.2027.87-266%
Returns for 10 years-76.3175.78-101%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BAX18.70N/A
N/A
Baxter International
OFG40.72-0.03
-0.07%
OFG Bancorp
CVGW21.90-0.23
-1.04%
Calavo Growers
FBIOP6.53-0.27
-3.97%
Fortress Biotech
ACRV2.07-0.21
-9.21%
Acrivon Therapeutics